{"aaData": [["AD000", "
\nNOTE: Includes nicotine polacrilex and other deterrents (AD900).\n Excludes anticoagulant antagonists (BL200,VT700);\n antifolate antagonists (VT102); antivenins (IM300);\n dialysis solutions (IR200); emetics (GA600); opioid\n antagonists (CN102).\n\n
\nNOTE: The "laxatives, other" subclassification (GA209) includes\n combination products. The digestant subclassification\n (GA500) includes any single-entity or combination product\n containing a digestive enzyme. Antacid and simethicone\n combinations are included in subclassification "antacids,\n other" (GA199).\n\n
\nINCLUDES:\nEXCLUDES:\n ANTI-INFLAMMATORY TOPICAL PRODUCTS\n SEE: DERMATOLOGICAL AGENTS (DE000), NASAL AND THROAT,\n TOPICAL (NT100), OPHTHALMIC AGENTS (OP100),\n OTIC AGENTS (OT000) AND RECTAL,LOCAL (RS000)\n PARATHYROID (HS600)\n INCLUDES ALL PRODUCTS AFFECTING CALCIUM REGULATION,\n EXCEPT VITAMIN D AND ITS ANALOGUES\n \nCOMBINATIONS:\n HORMONES,OTHER (HS950)\n INCLUDES ANDROGEN/ESTROGEN COMBINATION PRODUCTS AND THOSE NEC\n \n\n
\nNOTE: Drugs/devices used for investigational purposes are\n included in this classification.\n\n
\nNOTE: Excludes 50% dimethyl sulfoxide (GU900).\n\n
\nNOTE: The antigout subclassification (MS400) includes\n colchicine, uricosuric agents, and xanthine-oxidase\n inhibitors. The skeletal muscle relaxant\n subclassification includes all combinations, except those\n containing an opioid ingredient (CN101).\n\n
\nINCLUDES: ANESTHETICS, MUCOSAL (NT300)\n INCLUDES COCAINE\n\n
\nNOTE: The "anti-infectives, other" subclassification (OP209)\n includes products containing combinations from any one or\n more subclassifications (OP201,OP202,OP203) of anti-\n infectives, topical ophthalmic. The "ophthalmic, other"\n subclassification (OP900) includes all combination\n ophthalmics except those classified under "antiglaucoma\n combinations" (OP105), "anti-infective/anti-inflammatory\n combinations" (OP350) or "anti-infectives, other"\n (OP209).\n\n
\nNOTE: Includes topical fluoride products (OR100).\n Excludes sodium fluoride tablets (TN407).\n \n\n
\nNOTE: The "anti-infectives, other" subclassification (OT109)\n includes products containing combinations from any one or\n more subclassifications (OT101,OT102) of "anti-\n infectives, otic". The "otic, other" subclassification\n (OT900) includes all combination otic products except\n those classified under "anti-infective/anti-inflammatory\n combinations" (OT250), "otic analgesics" (OT400) or\n "anti-infectives,topical otic other" (OT109).\n\n
\nNOTE: Includes agents used in the preparation or reconstitution\n of pharmaceutical products. Includes diluents with separate\n NDC codes.\n\n
\nNOTE: The xanthine bronchodilator subclassification (RE104)\n subclassification (RE301). The "cold remedies, other"\n subclassification (RE599) contains all cold/cough\n preparations which were not included in subclassifications\n (RE200,RE301,RE302 or RE500) through (RE516).\n includes single-entity dyphylline-containing\n products. Antiasthma combination products containing two\n or more active ingredients from different\n subclassififcations are included in the "antiasthma, other"\n subclassification (RE109). Both single entity and\n combinations of antitussives and expectorants will be\n included in subclassifications (RE301) or (RE302). Any of\n these products with at least one opioid is included in\n\n
\nNOTE: Includes only those products administered rectally with\n local activity.\n Excludes products administered rectally for their\n systemic effect (e.g., acetaminophen suppositories (CN103)).\n\n
\nNOTE: Subclassifications (TN501) and (TN502) include kits and\n products containing dextrose.\n\n
\nNOTE: The oxytocic subclassification (GU600) includes 20%\n sodium chloride, 40 to 60% urea solutions, ergonovine,\n and methylergonovine but does not include oxytocin\n (HS702) or prostaglandins (HS875). The "antispasmodics,\n urinary" subclassification (GU201) includes single-entity\n products. The "antispasmodics urinary, other"\n subclassification (GU209) includes any combination\n containing an anticholinergic ingredient that is intended for\n genitourinary use.\n\n
\nNOTE: The "vitamin B, other" subclassification (VT109) includes\n combinations containing only vitamin B complex.\n Combinations containing only vitamin D are included in\n subclassification (VT509). Subclassification (VT709)\n includes combinations of vitamin K only. The "vitamins,\n other" subclassification (VT809) includes any product in\n which a vitamin is found in combination with an ingredient\n which is neither a vitamin nor a mineral.\n\n
\nNOTE: Urinary catheters and irrigation syringes are included in (XA500).\n Suction catheters are included in (XA900). Class (XA850) includes\n only syringes/needles for injectable use.\n\n
\nNOTE: Includes hormones (AN500) which are exclusively\n used as antineoplastics (e.g.,tamoxifen).\n Excludes other hormones (HS000).\n\n
\nALL SINGLE AGENT ALPHA BLOCKERS ARE LISTED IN THIS CATEGORY.\nINCLUDES BOTH PERIPHERAL AND CENTRAL\n\n
\nNOTE: Includes all products not elsewhere classified.\n\n
\nNOTE: Includes topical pediculicides (AP300).\n\n
\n ABBREVIATION INTERPRETATION\n (e.g., dermatological, ophthalmic). If a product is not classified by\n route of administration, it is classified in most instances under a\n specific chemical or pharmacological classification (e.g., beta-blockers\n , cephalosporins). If a product is not classified by route of\n administration, or chemical or pharmacological subclassification, it may\n be classified under a therapeutic category (e.g., antilipemic agents,\n antiparkinson agents).\n \n Most combination products are found in the "other" subclassification\n under each major classification unless a specific subcategory for\n \n combination products exists or a descriptive comment indicates inclusion\n elsewhere. In addition, products which are not adequately described by a\n minor category or subcategory within the major classification are\n classified as "other" (e.g., metronidazole, vancomycin).\n \n The "notes" included in the following classification file define\n assignment of codes for primary classifications only. These notes may or\n may not be applicable to any secondary classifications.\n NDC NATIONAL DRUG CODE\n NEC NOT ELSEWHERE CLASSIFIED\n \n Descriptive comments are included only when the classification\n system itself is not self-explanatory. The VA Drug Classification\n system classifies drug products, not generic ingredients. Drug\n products with local effects are classified by route of administration\n\n
\nNOTE: Includes products used only for the disinfection of\n inanimate objects and surfaces (e.g.,benzalkonium\n chloride).\n Excludes products used for the cleansing or disinfection\n of animate objects (e.g.,hexachlorophene (DE400)) and\n products used for the cleansing or disinfection of both\n animate and inanimate objects (e.g.,povidone iodine\n (DE101)).\n\n
\nNOTE: Includes single ingredient anticholinergic products used\n bronchodilators (RE105)), or ophthalmic (beta-blockers\n (OP101,OP107)) subclassifications; gastrointestinal tract\n antispasmodic combinations (GA802); and urinary tract\n antispasmodics (GU200).\n as antiparkinson agents (e.g.,benztropine,trihexyphenidyl\n (AU350)) and single ingredient anticholinergic products used as\n antispasmodics in the gastrointestinal tract\n (e.g.,glycopyrrolate).\n Excludes those products classified under selected\n cardiovascular (beta-blockers (CV100), alpha-blockers\n (CV150), antihypertensives (CV400,CV490)), respiratory\n (sympathomimetic bronchodilators (RE103), anticholinergic\n\n
\nINCLUDES: IRON/BLOOD FORMATION (BL400)\n PRODUCTS CONTAINING IRON SALTS AS SINGLE INGREDIENT OR IN \n COMBINATION WITH ASCORBIC ACID,CYANOCOBALAMIN,FOLIC ACID,\n OR INTRINSIC FACTOR\n\n
\nNOTE: The beta-blockers/related subclassification (CV100)\n subclassification.\n includes all single-entity beta-blockers and alpha-beta-\n blockers. Combinations containing a beta-blocker are\n included with the combination antihypertensives (CV400).\n The alpha-blockers/related subclassification (CV150)\n includes both peripheral and central single-entity\n products. All antihypertensive combinations, with the\n exception of potassium-sparing diuretics in combination\n with other diuretics (CV704), are included in the CV400\n\n
\nNote: Includes all medications introduced into the intrapleural space.\n\n
\nTHIS CLASSIFICATION WILL INCLUDE SINGLE AGENT BETA BLOCKERS AND\nALPHA-BETA BLOCKERS. SINGLE AGENTS ONLY. COMBINATIONS WILL BE\nINCLUDED IN CA400 ANTIHYPERTENSIVES,COMBINATIONS.\n\n
\nNOTE: Excludes H2-antagonists (GA301); combination cold\n products (RE500).\n\n
\nNOTE: Includes all single-entity and combination analgesic\n partial agonist opioid (RE301); antidiarrheal products\n containing tincture of opium or paregoric (GA400); single-\n entity anticholinergic products and dopamine agonists\n (AU350); pargyline (CV490); procarbazine (AN900);\n anesthetics, local topical (DE700).\n products containing an opioid agonist or partial\n agonist (CN101); non-opioid single-entity and combination\n analgesic products containing acetaminophen and/or\n salicylates (CN103); single-entity monocyclic,\n bicyclic, or tetracyclic antidepressants (CN609); and\n single-entity products containing a phenothiazine or\n thioxanthene (CN701).\n Excludes antitussive products containing an agonist or\n\n
\nNOTE: Combination products containing two or more active\n Beta-lactam antibiotics not classified under penicillins\n or cephalosporins are classified (AM130).\n Excludes topical anti-infectives (DE100), topical anti-\n infective/anti-inflammatory combinations (DE250),\n ophthalmic anti-infectives (OP200), ophthalmic anti-\n infective/anti-inflammatory combinations (OP350), otic\n anti-infectives (OT100), otic anti-infective/anti-\n inflammatory combinations (OT250); vaginal anti-\n infectives (GU300).\n ingredients from the same subclassification are\n classified in that subclassification (e.g.,triple sulfas\n in AM650). Products containing two or more active\n ingredients from different subclassifications are\n classified under "anti-infectives, other" (e.g.,\n tetracycline and amphotericin B (AM900). Products\n containing probenecid or clavulanic acid are classified\n under the subclassification of the antimicrobial agent.\n\n
\nNOTE: The topical anti-inflammatory subclassification (DE200)\n includes products containing combinations of agents from\n any one or more subclassification of anti-infectives,\n topical (DE101, DE102, DE103). Topical pediculicides are\n included under class AP300.\n includes all single-entity anti-inflammatory agents and\n all combinations containing an adrenocorticoid except\n those which also contain anti-infective agent (DE250)\n or an antipsoriatic agent (DE802). The topical\n antipsoriatic subclassification (DE802) includes products\n containing adrenocorticoids in combination with coal tar\n or salicylic acid and products containing coal tar. The\n "anti-infective, topical other" subclassification (DE109)\n\n